lifevantage reviews glp-1 reviews LifeVantage Corporation Q3 2026 Earnings

Adenosine A(2A) receptor antagonists in Parkinsons disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F

British Journal of Ophthalmology , 2026

Try flexible payments withLearn how 500+ products Advertisement * Pay in 4 : A higher initial payment may be required